Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Cavalieri

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 28, 2025
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trialPaolo Bossi, Andrea Alberti, Cristiana Bergamini, et al.
Frontiers in Oncology|October 19, 2020
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer PatientsNicola Alessandro Iacovelli, Alessandro Cicchetti, Anna Cavallo, et al.
Journal for Immunotherapy of Cancer|January 4, 2024
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single caseViviana Vallacchi, Elisabetta Vergani, Mara Cossa, et al.
The Lancet. Digital Health|April 16, 2026
Joint probability framework for the development and validation of a prognostic model for the conditional outcome of quality of life: a retrospective study in historical European cohorts of survivors of head and neck cancerMauricio Moreira-Soares, Erlend I F Fossen, Aritz Bilbao-Jayo, et al.
Head & Neck|March 4, 2025
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian CentersFrancesca Caspani, Stefano Cavalieri, Ester Orlandi, et al.
Frontiers in Oncology|January 19, 2024
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trialStefano Cavalieri, Eleonora Bruno, Mara Serena Serafini, et al.
Future Oncology (London, England)|March 28, 2023
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC)Stefano Cavalieri, Viviana Vitolo, Amelia Barcellini, et al.
Oral Oncology|October 1, 2023
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experienceStefano Cavalieri, Francesca Platini, Francesco Barretta, et al.
The Laryngoscope|August 2, 2019
Locally advanced epithelial sinonasal tumors: The impact of multimodal approachEster Orlandi, Stefano Cavalieri, Roberta Granata, et al.
Cancers|October 17, 2020
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma PatientsMarco Bologna, Valentina Corino, Giuseppina Calareso, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|March 28, 2025
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trialPaolo Bossi, Andrea Alberti, Cristiana Bergamini, et al.
Frontiers in Oncology|October 19, 2020
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer PatientsNicola Alessandro Iacovelli, Alessandro Cicchetti, Anna Cavallo, et al.
Journal for Immunotherapy of Cancer|January 4, 2024
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single caseViviana Vallacchi, Elisabetta Vergani, Mara Cossa, et al.
The Lancet. Digital Health|April 16, 2026
Joint probability framework for the development and validation of a prognostic model for the conditional outcome of quality of life: a retrospective study in historical European cohorts of survivors of head and neck cancerMauricio Moreira-Soares, Erlend I F Fossen, Aritz Bilbao-Jayo, et al.
Head & Neck|March 4, 2025
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian CentersFrancesca Caspani, Stefano Cavalieri, Ester Orlandi, et al.
Frontiers in Oncology|January 19, 2024
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trialStefano Cavalieri, Eleonora Bruno, Mara Serena Serafini, et al.
Future Oncology (London, England)|March 28, 2023
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC)Stefano Cavalieri, Viviana Vitolo, Amelia Barcellini, et al.
Oral Oncology|October 1, 2023
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experienceStefano Cavalieri, Francesca Platini, Francesco Barretta, et al.
The Laryngoscope|August 2, 2019
Locally advanced epithelial sinonasal tumors: The impact of multimodal approachEster Orlandi, Stefano Cavalieri, Roberta Granata, et al.
Cancers|October 17, 2020
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma PatientsMarco Bologna, Valentina Corino, Giuseppina Calareso, et al.
Pageof 14